Atlas Trials

Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

Clinical trial NCT04657666 · COMPLETED

Trial details

NCT number
NCT04657666
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Spasticity in Participants With Multiple Sclerosis
Start date
2020-12-21
Primary completion
2022-05-04
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.